The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of serious adverse events in bortezomib, lenalidomide and bortezomib plus lenalidomide maintenance for multiple myeloma: Interim analysis of MMRF-CoMMpass study.
 
Venkata Vosuri
No Relationships to Disclose
 
Mark A Fiala
No Relationships to Disclose
 
Wenners Ballard
No Relationships to Disclose
 
Tanya Marya Wildes
Honoraria - Carevive Systems
Research Funding - Janssen Oncology (Inst)
 
Mark A. Schroeder
Consulting or Advisory Role - Amgen; Flatiron Health; Incyte; Partners Therapeutics; Pfizer; Sanofi
Speakers' Bureau - Merck; Takeda
 
Ravi Vij
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Dava Oncology; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
 
Keith Stockerl-Goldstein
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie
Consulting or Advisory Role - Celgene
Research Funding - BiolineRx; GlaxoSmithKline; Janssen; Takeda
Other Relationship - Cellerant